Company intelligence / Profile preview

Ascent Pharmaceuticals

Central Islip, New York, United Statesascentpharm.com ↗

Ownership: Private
Employees: ~100
Development stage: Other

Overview

Ascent Pharmaceuticals is a commercial-stage generic drug manufacturer with over 31 marketed products in the United States, focusing on providing affordable medicines across multiple therapeutic areas.

Therapeutic areas: NeurologyPsychiatryInfectious DiseasesEndocrinologyImmunologyCardiovascular
Modalities: Small molecule (generic drugs in tablet and capsule forms)
Industry: Biotech

Partnerships

None specifically disclosed; operates independently but is part of Hetero Group which may have broader partnerships.

Beyond the preview

Go deeper on Ascent Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ascent Pharmaceuticals.

Explore the full profile